Cigarette smoke induces systemic defects in cystic fibrosis transmembrane conductance regulator (CFTR) ion transport
S. V. Raju, P. Jackson, C. Courville, C. McNicholas, P. A. Sloane, G. Sabbatinin, L. P. Tang, M. Mazur, J. P. Clancy, F. J. Accurso, J. E. Blalock, M. T. Dransfield, S. M. Rowe (Birmingham, Denver, Cincinnati, United States Of America)
Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science
Session: Cystic fibrosis: basic and applied science
Session type: Poster Discussion
Number: 2102
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. V. Raju, P. Jackson, C. Courville, C. McNicholas, P. A. Sloane, G. Sabbatinin, L. P. Tang, M. Mazur, J. P. Clancy, F. J. Accurso, J. E. Blalock, M. T. Dransfield, S. M. Rowe (Birmingham, Denver, Cincinnati, United States Of America). Cigarette smoke induces systemic defects in cystic fibrosis transmembrane conductance regulator (CFTR) ion transport. Eur Respir J 2013; 42: Suppl. 57, 2102
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Cystic fibrosis transmembrane conductance regulator pharmacotherapy Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=88 Year: 2006
Targeting a genetic defect: cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis Source: Eur Respir Rev 2013; 22: 58-65 Year: 2013
Atypical cystic fibrosis Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=38 Year: 2006
LATE-BREAKING ABSTRACT: Reducing inflammation in the lung by targeting the endothelial cystic fibrosis transmembrane conductance regulator with copper-tobramycin Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014
A three miRNA signature regulates the CF transmembrane conductance regulator (CFTR) in cystic fibrosis airway epithelium Source: Annual Congress 2011 - Epithelial cells: role in health and disease Year: 2011
Cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID) Source: Breathe, 17 (3) 210088; 10.1183/20734735.0088-2021 Year: 2021
The cystic fibrosis transmembrane conductance regulator: state of the art Source: Breathe 2008; 5: 163-167 Year: 2008
Oral contraceptives do not appear to affect cystic fibrosis disease severity Source: Eur Respir J 2013; 41: 67-73 Year: 2013
Lung function, weight, and sweat chloride responses in patients with cystic fibrosis and the G551D-CFTR mutation treated with ivacaftor: A secondary analysis Source: Annual Congress 2013 –Cystic fibrosis: lung function and change of lung function in infants and children before and after treatment Year: 2013
Channelopathies in bronchiectasis Source: Eur Respir Mon 2011; 52: 150-162 Year: 2011
The cystic fibrosis transmembrane conductance regulator and its modulators: clinical implications Source: Virtual Congress 2020 – Respiratory infections Year: 2020
Cystic fibrosis and survival to 40 years: a study of cystic fibrosis transmembrane conductance regulator function Source: Eur Respir J 2011; 37: 1076-1082 Year: 2011
Identification of a new cystic fibrosis transmembrane regulator mutation in a severely affected patient Source: Eur Respir J 2002; 19: 374-376 Year: 2002
CFTR: cystic fibrosis and beyond Source: Eur Respir J 2014; 44: 1042-1054 Year: 2014
Increased systemic inflammation in cystic fibrosis (CF) is associated with deterioration in lung clearance index (LCI) Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014
Cross-talk of inflammatory mediators and airway epithelium reveals the cystic fibrosis transmembrane conductance regulator as a major target Source: ERJ Open Res, 7 (4) 00247-2021; 10.1183/23120541.00247-2021 Year: 2021
Expression and function of cystic fibrosis transmembrane conductance regulator in rat intrapulmonary arteries Source: Eur Respir J 2007; 30: 857-864 Year: 2007
Cystic fibrosis: to ion transport and beyond Source: Eur Respir J 2010; 36: 991-992 Year: 2010
Deleterious impact of Pseudomonas aeruginosa on cystic fibrosis transmembrane conductance regulator function and rescue in airway epithelial cells Source: Eur Respir J 2015; 45: 1590-1602 Year: 2015